Core Viewpoint - The article discusses the launch of the "2026 Medical and Health Sustainable Innovation Case Recommendation List," emphasizing the integration of artificial intelligence in the healthcare industry to promote sustainable development [2]. Group 1: Categories of Case Collection - The recommendation list includes four categories: "International Innovation Localization," "Local Innovation Globalization," "ESG Innovation Practice," and a new category "Healthcare + AI Innovation" to address the transformative impact of AI on the healthcare sector [2][3]. Group 2: International Innovation Localization - This category focuses on local research and intellectual property accumulation, compliance systems, local manufacturing and supply chain integration, local organizational and talent development, and contributions to the Chinese healthcare system [3]. Group 3: Local Innovation Globalization - This category evaluates product innovation capabilities, clarity of international market entry paths, overseas collaboration networks, international team operations, and measurable international impact [4]. Group 4: ESG Innovation Practice - This category assesses the systematic nature of ESG strategies and governance structures, quantifiable environmental responsibilities, social responsibilities, employee development, and supply chain ESG management [5]. Group 5: Healthcare + AI Innovation - This category emphasizes real-world applications addressing industry pain points, sustainable business models, digital capabilities, compliance and security governance, technology maturity, and long-term potential [6]. Group 6: Evaluation Process - A nomination committee composed of 20 senior professionals from the healthcare sector will ensure an objective evaluation process, involving case reviews, online interviews, and comprehensive assessments [8]. Group 7: Timeline for Case Collection and Evaluation - The timeline for the case collection and evaluation includes: - January to March 2026: Case collection through self-nomination or committee nomination - April to May 2026: Initial screening and interviews - June 2026: Comprehensive evaluation by the nomination committee - July 2026: Official release of the list at the Shanghai World Artificial Intelligence Conference [15].

Core Viewpoint - The "2026 Medical and Health Sustainable Innovation Case Recommendation List" aims to promote sustainable development in the healthcare industry through the integration of artificial intelligence and healthcare, with a focus on technological innovation [1]. Group 1: Categories of Case Collection - The case collection includes four categories: 1. **International Innovation Localization**: Focuses on local production of innovative products, investment in local enterprises, and localization of marketing and services [2]. 2. **Local Innovation Globalization**: Emphasizes product innovation and quality assurance, establishing localized networks overseas, and enhancing brand visibility in international markets [2]. 3. **ESG Innovation Practice**: Involves sustainable market strategies, community services, and a sustainable supply chain [2]. 4. **Healthcare + AI Innovation**: Aims to address industry pain points, improve diagnostic efficiency, and ensure data security while promoting healthcare accessibility [2]. Group 2: Evaluation Committee - The evaluation committee consists of 20 senior professionals from both domestic and foreign healthcare sectors, including executives, policymakers, and experts from investment institutions [4]. Group 3: Timeline for Case Collection and Evaluation - The timeline for the case collection and evaluation process is as follows: - **January to March 2026**: Case collection through self-nomination or committee nomination [9]. - **April to May 2026**: Initial screening and online interviews with shortlisted companies [9]. - **June 2026**: Comprehensive evaluation by the nomination committee [9]. - **July 2026**: Official release of the list at the "AI + Healthcare Industry Sustainable Innovation Forum" during the Shanghai World Artificial Intelligence Conference [9].

Core Viewpoint - The article highlights a significant breakthrough in cell therapy with the development of a "DMSO-free cryopreservation solution" for stem cells, which enhances safety and efficacy in clinical applications [1][2][4]. Group 1: Technological Breakthroughs - The new cryopreservation solution eliminates the toxic effects associated with traditional DMSO-containing solutions, reducing risks of nausea, allergies, and kidney damage upon reintroduction into the body [1][2]. - The solution has shown a substantial increase in survival rates in immunodeficient mice during animal trials, indicating its potential for clinical use [1]. - The "Haiyi Hui" platform has facilitated the development of over ten disruptive technologies in various fields, including blood health, cell and gene therapy, and AI applications in major diseases [4][6]. Group 2: Collaborative Ecosystem - The "Haiyi Hui" platform connects hundreds of academicians and clinical scientists with industry engineers and capital, aiming to bridge the gap between research and clinical application [7][8]. - The platform has conducted over 600 distributed clinical trials, demonstrating its role as a vital practice carrier for overcoming industry bottlenecks in technology transfer [8]. - The integration of AI technology is emphasized as a core driver for accelerating the transformation of scientific discoveries into clinical applications, enhancing the efficiency and accessibility of healthcare services [10][14]. Group 3: Educational Initiatives - The "Yingkang Yisheng Public Welfare Fund" has launched initiatives to support the cultivation of interdisciplinary talents and accelerate the implementation of innovative results, with over 100 key projects funded in the first phase [10][11]. - The second phase of the "Innovation Elite Cultivation Plan" aims to further expand collaboration and deepen training systems that connect basic research, clinical practice, and technology transfer [11][13]. Group 4: Future Implications - The article suggests that the future of medical innovation will be measured by the ability to create efficient, open systems that continuously translate scientific discoveries into patient benefits, rather than merely by the number of publications or patents [9][15]. - The average valuation of entities joining the "Haiyi Hui" has reportedly increased sixfold, indicating a significant value reassessment driven by ecosystem collaboration [9].

Core Points - The 2025 China International Service Trade Fair (CIFTIS) will be held from September 10 to 14 in Beijing, focusing on health and wellness services with the theme "Smart Leading the Future, Healthy Living" [1] - The event will feature two main exhibition areas: "Smart Therapy Cloud Matrix" and "National Health Service Matrix," showcasing innovative products and technologies in AI and healthcare [2][3] - The fair will host nearly 20 conferences and forums, including the Capital International Medical Conference, discussing topics such as technological innovation, healthcare industry development, and international cooperation [6] Exhibition Areas - The "Smart Therapy Cloud Matrix" will present 15 stages of AI-driven biomedical research and development, highlighting advanced cases in diagnostic models and AI application [3] - The "National Health Service Matrix" will focus on health management, elderly care, and traditional Chinese medicine, featuring lectures and exhibitions on health topics [4] Participation and Internationalization - The fair has achieved a 54% participation rate from Fortune 500 and industry-leading companies, with an internationalization rate of 53% [3] - A total of 48 institutions will participate in the traditional Chinese medicine theme, with 27 offline exhibitors, marking a record high [7] Cultural and Interactive Activities - The event will include cultural exchange activities, such as the "Traditional Chinese Medicine 24 Solar Terms Health Check-in," enhancing public engagement through interactive experiences [8]

Core Viewpoint - The 2025 China International Service Trade Fair (CIFTIS) will focus on health and wellness services, featuring advanced technologies and innovations in the integration of artificial intelligence and healthcare, with the theme "Intelligent Leading the Future, Healthy Living" [1][3]. Group 1: Event Overview - The CIFTIS will take place from September 10 to 14 in Beijing, showcasing two main exhibition areas: "Intelligent Therapy Cloud Matrix" and "Universal Health Service Matrix" [1][3]. - The event will host nearly 20 conferences and forums, including the Capital International Medical Conference [5][6]. Group 2: Exhibition Highlights - The health service exhibition will feature a total participation rate of 54% from Fortune 500 and industry-leading companies, with an international participation rate of 53% [3]. - The "Intelligent Therapy Cloud Matrix" will present 15 stages of AI-driven biomedical research and development, highlighting advanced cases such as diagnostic models and AI result transformation [3]. Group 3: Focus Areas - The "Universal Health Service Matrix" will cover health management, elderly care, and traditional Chinese medicine, offering public health lectures and showcasing innovative projects from Beijing's medical institutions [4]. - The event will also emphasize the "Beijing Service" brand case studies [4]. Group 4: International Collaboration and Innovation - The Capital International Medical Conference will include discussions on technology innovation, healthcare industry development, and international cooperation, featuring renowned experts and institutions [6]. - The conference will release significant research findings, including the "BMJ China Hospital Clinical Research International Influence Report" and the "Digital Medical Blue Book" [6]. Group 5: Traditional Chinese Medicine (TCM) Initiatives - The TCM theme will feature 48 participating institutions, with 27 exhibiting offline, marking a record high for participation from leading TCM organizations [7]. - The event will include four TCM-themed forums and a policy seminar, focusing on international development and digitalization of TCM [7][8].